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Expanding the chemistry of fluorescent protein
biosensors through genetic incorporation of
unnatural amino acids
Wei Niu and Jiantao Guo*
Fluorescent proteins are essential tools in biological research, ranging from the study of individual
biological components to the interrogation of complex cellular systems. Fluorescent protein derived
biosensors are increasingly applied to the study of biological molecules and events in living cells. The
present review focuses on a specific class of fluorescent protein biosensors in which a genetically
installed unnatural amino acid (UAA*) acts as the sensing element. Upon direct interaction with the
analyte of interest, the chemical and/or physical properties of UAA* are altered, which triggers
fluorescence property changes of the biosensor and generates readouts. In comparison to mutagenesis
approaches within the standard genetic code, introduction of UAA*s with a unique functionality and
chemical reactivity could broaden the scope of analytes and improve the specificity of biosensors.
Nonconventional functional groups in fluorescent proteins enable sensor designs that are not readily
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accessible using the common twenty amino acids. Recent reports of UAA*-containing fluorescent
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integration of the two powerful chemical biology tools, fluorescent protein sensors and genetic

protein sensors serve as excellent examples for the utility of such sensor design. We envisage that the
incorporation of UAA*s, will lead to novel biosensors that can expand and deepen current under-
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standing of cellular processes.

1. Introduction
Fluorescent proteins are useful probes for the study of biological
molecules and processes.1–6 Since the discovery and subsequent
cloning of the green fluorescent protein (GFP) from the jellyfish
Aequorea victoria,7 many variants of fluorescent proteins have
been isolated or engineered to give a color palette, which
enables the monitoring of cellular processes in living systems
under physiological conditions using fluorescence microscopy, fluorescence-activated cell sorting, and other related
methodologies1–4,8 Information extracted from these experiments
leads to an unprecedented era of biological discovery. In recognition of the importance of fluorescent proteins in modern biological,
biochemical, and biomedical research, the 2008 Nobel Prize in
Chemistry was awarded to three researchers, Drs Osamu
Shimomura, Martin Chalfie, and Roger Y. Tsien, for their key contributions to the discovery and development of fluorescent proteins.
In addition to many established applications in cellular biology,
increasing numbers of examples focus on the design and the use of
fluorescent proteins as biosensors to track biological molecules and
events in living cells.2,3 Genetically encoded fluorescent protein (FP)
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biosensors that provide real-time information on cellular activities
with high spatiotemporal resolution are becoming indispensable
tools in biological studies. In addition to superior physical properties of fluorescence signal detection, an FP biosensor can be easily
introduced into the subject of interest in the form of DNA and be
propagated as a part of the subject’s genetic material. The FP
biosensor itself is synthesized by the host’s transcriptional and
translational machinery and becomes an intrinsic part of the
cellular system. Such genetically encoded biosensors cause
limited perturbation to the intracellular environment. They are
suitable for applications in sub-cellular compartments of individual cells, tissues, or even whole animals. Since the first publication of a green fluorescent protein (GFP) Ca2+ biosensor in
1997,9 over 100 diﬀerent genetically encoded FP biosensors have
been developed to monitor intracellular pH, redox potential,
enzyme activities, and concentrations of small molecules.2,3
The traditional design and construction of FP biosensors are
based on the standard genetic code, which restricts the FP
biosensor engineering to the common twenty amino acids and
their relatively limited number of functional groups. An intriguing question is whether the introduction of non-canonical
functional groups with novel physical, chemical, and biological
properties through genetic incorporation of unnatural amino
acids (UAA*s) into FPs could further diversify the proteins’

Mol. BioSyst., 2013, 9, 2961--2970

2961

View Article Online

Review
structure and function and lead to novel designs of FP biosensors. The combination of FP engineering and UAA* mutagenesis methods will provide a new frontier for the design and
construction of FP biosensors,10–14 which is the main focus of this
review. The intention of this review is to attract more attention
towards this emerging research field and to provoke creative
designs and innovative utilization of FP biosensors containing
unnatural elements for biological studies in living systems.

2. Genetic incorporation of unnatural amino
acids (UAA*s)
Genetic codes of all known organisms encode the same set of
twenty amino acids with rare exceptions in selenocysteine and
pyrrolysine. The side chains of these amino acids contain a
limited number of functional groups, which restricts our ability
to probe and manipulate protein structure and function. To
overcome this barrier, a number of methods were developed to
introduce UAA*s into proteins in living cells: (1) microinjection
of Xenopus oocytes with a chemically misacylated Tetrahymena
tRNA and a mutant mRNA with an amber nonsense codon
resulted in the selective incorporation of UAA*s into proteins
in response to amber codons;15–17 (2) taking advantage of the
substrate promiscuity of aminoacyl-tRNA synthetases, E. coli
auxotrophy that cannot synthesize a particular amino acid was
supplemented with an analog of this amino acid.18 Cells were
able to produce mutant proteins in which the unnatural analog
replaced the specific natural amino acid at all positions.19 This
method can only be used to incorporate structurally similar
analogs of a natural amino acid into proteins, such as fluorinated amino acid for 19F NMR study20 and methionine analogs,
selenomethionine and telluromethionine, as heavy atoms for
phase determination in X-ray crystallography.21,22 The scope of
this method can be expanded by relaxing the substrate specificity23–25 or impairing proofreading functions of aminoacyl-tRNA
synthetases;26 (3) a general approach for the site-specific incorporation of UAA*s into proteins in living bacterial, yeast, and
mammalian cells has recently been developed.27–30 In this
system, orthogonal tRNA–aminoacyl-tRNA synthetase pairs are
generated to recognize a noncoding codon (also called a ‘‘blank
codon’’, which does not encode a natural proteinogenic amino
acid, such as the amber nonsense codon) and not to cross-react
with any of the endogenous tRNAs and synthetases in the host
strain. The orthogonal aminoacyl-tRNA synthetase is then modified to aminoacylate the cognate tRNA specifically with the
desired UAA*. This method enabled high-efficiency incorporation of over seventy UAA*s with a variety of side chain structures
and functions, including spectroscopic probes, metal chelators,
posttranslational modification analogs, redox-active groups, and
probes with unique chemical reactivities.27–30

3. Basic design principles of FP biosensors
Current FP biosensors are engineered by following several design
principles (Fig. 1). In the first design (Fig. 1A), two compatible
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FP(s) are fused to a protein scaﬀold that acts as the sensing
domain for the target recognition. Upon exposure to biological
stimuli, the sensing domain undergoes a dramatic conformational change that leads to a change in the relative distance
between the two fused FPs and results in a shift in the fluorescence resonance energy transfer (FRET) signal.2,3,6 A well-known
example is the ‘‘cameleon’’ class of Ca2+ sensors31,32 in which the
FP FRET pair is fused to a sensing domain containing calmodulin
and a peptide that binds to calmodulin in the presence of Ca2+,
respectively.53,54 The second design is based on bimolecular
fluorescence complementation (BiFC; Fig. 1B).6,33 The commonly
known ‘‘split’’ FP approach entails the co-expression of two fusion
proteins, while each contains half of the split FP and one part of
the sensing domain. Association of the sensing domains in the
presence of an analyte of interest brings the complementary fragments of the FP reporter within close proximity, promotes the
reconstitution of the reporter FP into its native three-dimensional
structure and the emission of the fluorescence signal. The
‘‘split’’ FP approach is commonly used to detect transient
protein–protein interactions. Efforts are also devoted to building ‘‘split’’ FP biosensors to detect specific analytes. A classic
example of such a split FP-biosensor is the split-pericam,34
which responds to Ca2+ ions. The third general design is a class
of single FP-based biosensors (Fig. 1C).2,3,6 It is known that
the surrounding molecular environment of an FP’s chromophore defines its fluorescence signature. Here, an FP, usually a
circularly permuted FP (cpFP), is fused to a protein scaffold(s)
that acts as a sensing domain. Upon recognition of the target,
the sensing domain causes a conformational change of the FP
(or cpFP) and leads to a shift in the fluorescence intensity
and/or the fluorescence hue. One representative example is a
genetically encoded Ca2+ sensor, G-CaMP,35 which has the M13
fragment of myosin light chain kinase and the calmodulin
domain fused to the N- and C-terminus of a cpEGFP, respectively. The Ca2+-induced interaction between calmodulin and
M13 domains leads to conformational and fluorescence property changes of the cpEGFP.
Although current approaches to design FP biosensors are
fairly straightforward, significant challenges remain in order to
improve the specificity, the sensitivity, and the diversity of FP
biosensors. Sensing elements of current FP biosensors are
either naturally existing proteins, such as transcription factors,
or engineered sensing moieties based on the chemistry of
natural amino acids (e.g., disulfide bond formation by cysteine
residues). Such designs not only limit the specificity and the
aﬃnity of FP biosensors, but also restrict the types of analytes
that can be eﬃciently detected. Furthermore, due to the signature multi-domain architecture, sensitivities of current FP
biosensors are often dominated by their tertiary structures. The
optimization of the spatial arrangement between the FP and
the sensing element often relies on a trial and error approach
with limited theoretical guidance.
We and others have been seeking to develop a novel group of
FP biosensors through modifications of the natural chromophore of GFP variants with UAA*s. The amber suppression
method is used to genetically incorporate UAA*s with unique
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Fig. 1 Basic design principles of fluorescent protein (FP) biosensors. (A) The FRET-based FP biosensor; (B) the bimolecular fluorescence complementation (BiFC)-based
FP biosensor; (C) the single FP-based biosensor; (D) the biosensor that is based on single FP containing UAA*s.

chemical and/or physical properties at defined positions of a
chromophore. The chromophore of GFP is derived from a
tripeptide sequence through a series of sequential chemical
reactions, including the internal cyclization of Gly67 and Ser65,
the dehydration reaction to form an imidizolin-5-one intermediate, and the final dehydrogenation reaction to complete
the conjugation of the ring system.5,36–43 The structure of an
FP’s chromophore is the major factor that defines its fluorescence signature. The novel UAA*-containing FP biosensor
design aims to produce the maximum signal output by directly
modifying chemical compositions of chromophores. Specifically, residue Tyr66 in the tripeptide sequence of GFP (or
functionally equivalent residues of other FPs) is replaced with
an UAA* bearing a side chain that either selectively reacts with
or has high affinity towards the analyte of interest (Fig. 1D).
A chemical transformation or a chelation event of the UAA*containing chromophore leads to fluorescence property changes
of the FP biosensor. Four desirable intrinsic properties are
associated with this class of novel FP sensors: (1) high specificity;
(2) large signal enhancement; (3) bioorthogonal to most cellular
events; and (4) genetically encodable. The basic design principle
also enables the direct transformation of many well-established
aqueous phase chemical reactions into biological format and
thus expands the repertoire of analytes that can be detected. This
review will focus on the newly developed UAA*-containing FP
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Fig. 2 UAA*s used in FP biosensors. Abbreviations: L-DOPA, 3,4-dihydroxyL-phenylalanine; pAzF, para-azido-L-phenylalanine; ONBY, o-nitrobenzyl-O-tyrosine;
pBoF, para-borono-L-phenylalanine; HqAla, 2-amino-3-(8-hydroxyquinolin-5-yl)propanoic acid.

biosensors for transition metals (Cu2+ and Zn2+),10,13 hydrogen
peroxide (H2O2),11 hydrogen sulfide (H2S),12 and light detection.14 UAA*s (Fig. 2) that are successfully applied to the biosensor design include 3,4-dihydroxy-L-phenylalanine (L-DOPA;
metal ion sensor),10,45 2-amino-3-(8-hydroxyquinolin-5-yl)propanoic acid (HqAla; metal ion sensor),13 para-borono-L-phenylalanine (pBoF; H2O2 sensor),11,44 para-azido-L-phenylalanine
(pAzF; H2S sensor),12,45 and o-nitrobenzyl-O-tyrosine (ONBY,
light-responsive FP).14,46
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4. Transition metal sensors
Unique chemical properties of transition metal ions render
them indispensable catalytic and structural components of
many proteins that participate in a wide variety of cellular
functions. Transition metal homeostasis is a delicate balance
within a complicated network of uptake, storage, secretory, and
regulatory pathways. Our knowledge of transition metal homeostasis is often inferred from the in vitro characterization of
individual components, instead of direct monitoring of actual
concentrations and changes within a single cell. Current most
advanced transition metal FP biosensors are FRET-based Zn2+
sensors (eCALWYs) that have picomolar sensitivity.47 FP biosensors for other transition metals, such as Cu2+, Cu+, Fe2+ and
Mn2+, are either at very early development stage or nonexistent.
The major challenge in transition metal sensor design lies in
the requirement of high selectivity among varieties of transition
metal ions inside the cells and high sensitivity to analytes that
often exist at low concentrations. This problem may be tackled
by incorporating metal-binding amino acids, such as L-DOPA,10,48
8-hydroxyquinolin-L-alanine (HQA),49 HqAla,13 and bipyridyl50
L-alanine (BpA),
into fluorescent proteins.
Single GFP-based in vitro Cu2+ sensors have been developed
by the introduction of histidine and cysteine residues as
copper-binding sites, which results in fluorescence quenching
upon binding to Cu2+.51–54 To further improve the sensitivity
and selectivity towards Cu2+, Ayyadurai and co-workers10 constructed a novel FP-based sensor by replacing all tyrosine
residues in the GFP with metal-chelating L-DOPA.10 The resulting GFPdopa mutant displayed good selectivity towards Cu2+
over other metal ions, including K+, Mg2+, Ca2+, Na+, Cd2+, Co2+,
Mn2+, Ni2+, and Zn2+. A 50% fluorescence quenching was
observed at the Cu2+ concentration of 20 mM, and a complete
quenching occurred at 100 mM of Cu2+. Ayyadurai and co-workers
proposed that the introduction of L-DOPA at positions Tyr66
(chromophore forming tyrosine residue) and Tyr92 might contribute the most to the observed response of GFPdopa to Cu2+.
Presumably, Cu2+ binds to the chromophore via interactions
with DOPA66-His148 and DOPA92-chromophore chelation pairs
(Fig. 3A). To demonstrate the utility of GFPdopa, Ayyadurai and
co-workers constructed a sensor chip by fabricating GFPdopa
patterns on the amine-coated glass surface using soft lithography. The fluorescence of the resulting sensor could be
quenched with a linear behavior upon the addition of different
concentrations of Cu2+. On the other hand, the biosensor
showed good reversibility when Cu2+ was removed by ethylenediaminetetraacetic acid (EDTA). Densitometry analysis revealed
that 94% of the original fluorescence intensity of GFPdopa could
be recovered with EDTA treatment. The copper dissociation
constant of GFPdopa was shown to be 5.6 mM, which makes it
relevant for Cu2+ detection under certain disease conditions55–57
and in environmental applications.
The second example of a metal ion sensor came from a
recent work of Liu and co-workers who site-specifically modified the chromophore of a circularly permutated sfGFP variant
by replacing Tyr66 with a metal binding amino acid, HqAla
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Fig. 3 Metal-binding amino acid-containing FP biosensors for metal ion detection. (A) The Cu2+ sensor based on L-DOPA; (B) the Zn2+ sensor based on HqAla;
(C) the Cu2+ sensor based on HqAla.

(Fig. 2 and 3B).13 The resulting FP biosensor, cpsfGFP-66HqAla, showed fluorescence decrease in the presence of Cu2+,
Fe2+, Co2+ and Ni2+, and significant fluorescence increase
(7.2-fold) with Zn2+. It shows little response to other metal
ions, including Na+, K+, Mg2+, Ca2+, and Mn2+ (all less than
1.3-fold change in fluorescence intensity).13 In addition to
changes in fluorescence intensity, the binding of Zn2+ also
caused blue-shift in the absorption maximum (from 537 nm,
the apo form, to 495 nm, the Zn2+-bound form) and emission
maximum (from 550 nm, the apo form, to 540 nm, the Zn2+bound form) of the sensor. Due to the importance of the Zn2+
ion in various biological processes, such as enzyme catalysis,
cellular metabolism, gene expression, and neurotransmission,
genetically encoded Zn2+ sensors with good sensitivity and
selectivity are useful tools for in vivo monitoring. Unfortunately,
the binding aﬃnity of cpsfGFP-66-HqAla to Zn2+ is weak with
an estimated KD value of 50–100 mM. Since the concentration of
the Zn2+ ion ranges from sub-nanomolar in mammalian
cells47,58–61 to about 300 mM in the mossy fiber terminals of
the hippocampus,62,63 this sensor is only applicable to measuring intracellular Zn2+ ion concentrations under limited physiological states.
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Liu and co-workers also constructed and examined sfGFP151-HqAla (Fig. 3C) as a metal ion sensor.13 Since position 151
locates close to the chromophore of sfGFP, the binding of Cu2+
to HqAla was predicted to quench the GFP fluorescence
through photoinduced electron transfer. In fact, a 65% quenching of fluorescence was observed in the presence of 1 mM of
Cu2+. The competitive metal capture analysis of sfGFP-151HqAla showed an apparent KD value of 0.1 fM towards Cu2+.
The above proof-of-concept designs successfully demonstrate the feasibility of using metal binding UAA*s as the
sensing element in FP metal biosensors. The initial success
should promote further eﬀorts into improving the selectivity
and sensitivity of the above metal ion sensors through creative
protein engineering and/or screening additional UAA*s with
better selectivity and aﬃnity to metal ions.

5. Hydrogen peroxide (H2O2) sensors
Hydrogen peroxide (H2O2) is an important second messenger
that participates in the control of intracellular signaling
cascades in response to external stimuli.64–68 Methods that
can be used to image intracellular concentration of H2O2 are
highly desirable. A few small-molecule fluorescent probes have
been designed based on the chemoselective reaction of arylboronates with H2O2.69 These probes are highly specific for
H2O2 and are bioorthogonal to most cellular processes. In order
to generate intracellular H2O2 biosensors with good spatial
resolution, a family of genetically encoded H2O2 sensors,
Hyper,70 Hyper-2,71 and Hyper-3,72 were constructed by inserting a circularly permuted yellow fluorescent protein (cpYFP)

Review
variant into the flexible region of the bacterial H2O2 transcription regulator (OxyR). Upon exposure to H2O2, the formation of
a new disulfide bond in OxyR promotes the conformational
change of the cpYFP and leads to enhanced fluorescence. A
second class of a genetically encoded H2O2 sensor, roGFP2Orp1,73 is based on peroxidase-roGFP relays. Both Hyper and
roGFP2-Orp1 families of sensors selectively respond to H2O2
but lead to less than 5-fold signal enhancements.
As an attempt to combine the sensitivity of arylboronatebased small-molecule fluorescent probes and the genetic
encodability of FP biosensors, we have successfully constructed
a H2O2 FP biosensor (UFP-Tyr66pBoPhe, Fig. 4A) by replacing
the natural chromophore-forming Tyr66 residue of GFP with
genetically incorporated pBoF (Fig. 2).11 As shown in Fig. 4A,
the arylboronate side chain of pBoF can be selectively oxidized
by H2O2 in aqueous solution, which coverts the unnatural
chromophore back to the wild-type chromophore of GFP. The
signal output is derived from the fluorescence property diﬀerence between the unnatural and the wild-type chromophores.
Therefore, the larger the quantum yield diﬀerence at specific
wavelengths between the mutant and the wild-type GFP, the
better the signal output of the biosensor. Interestingly, the GFP
Tyr66pBoF mutant is not fluorescent, thus serving as an
excellent starting point for the H2O2 sensor design. This
observation may be attributed to the vacant 2p orbital of boron,
which can readily accept electrons and makes the chromophore
more electron deficient. Furthermore, based on the crystal
structure of the GFP mutant,11 the pBorono group rotates a
small angle relative to the main plane of the chromophore due
to its hydrogen bonding to the backbone nitrogen of His148

Fig. 4 pBoF-based FP biosensors for H2O2 detection. (A) Transformation of the chromophore containing arylborate in the presence of H2O2; (B) fluorescence of UFPTyr66pBoPhe before (blue) and after (red) H2O2 treatment; (C) H2O2 concentration-dependent fluorescence changes of UFP-Tyr66pBoPhe; (D) and (E), overlapped
bright-field and fluorescence images of E. coli; (D) E. coli expressing UFP-Tyr66pBoPhe before H2O2 treatment; (E) E. coli expressing UFP-Tyr66pBoPhe after a 15-minute
treatment with H2O2.
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and to the hydroxyl side chain of Ser205. The bulky borono side
chain also clearly pushes the His148 away from the chromophore. These structural changes could also contribute to the
lack of any observed fluorescence.
After incubation with H2O2, the UFP-Tyr66pBoPhe biosensor
emits strong fluorescence, which has the identical spectral
property to that of the GFPUV (l = 508 nm) (Fig. 4B). The
fluorescence intensity change correlated very well with the
concentration of H2O2 in the micromolar range (Fig. 4C). In
vitro characterization of the purified FP sensor showed
response to H2O2 in the low micromolar range, which is above
the normal physiological intracellular H2O2 concentration
(0.01–0.7 mM),67,74,75 but overlaps with the H2O2 concentration
when cells are under oxidative stresses.69,76 The detection limit
of this sensor is comparable to the boronate-based smallmolecule fluorescent probes.69 In comparison to the best
reported H2O2 FP sensors (Hyper, Hyper-2, and Hyper-3),70–72
this new sensor is less sensitive but has an over 20-fold
improvement in signal output. Next, we demonstrated the
H2O2 sensor in living cells. As shown in Fig. 4E, addition of
H2O2 into a bacterial culture expressing the UFP-Tyr66pBoPhe
sensor led to the transformation of non-fluorescent cells into
cells with bright green fluorescence. As a control, no fluorescence intensity change was detected with native host E. coli in
the presence of H2O2 (Fig. 4D). Confocal fluorescence microscopy analysis also confirmed that the oxidation of UFP-Tyr66pBoPhe by H2O2 occurred inside E. coli cells (Fig. 4E).
Unlike the reversible disulfide bond formation reaction in
Hyper57,79,80 and roGFP2-Orp1,73 the oxidation of an arylboratebased FP biosensor by H2O2 is irreversible. Therefore, the
output signal of this type of biosensor is insensitive (bioorthogonal) to the rapidly recovered cellular redox state after a
transient H2O2 burst. The intrinsic stability of arylborate-based
FP biosensors could potentially simplify the imaging procedure
in live cell studies. In addition, this type of sensor can be
applied to monitoring the accumulative H2O2 signal in biological systems.

6. Hydrogen sulfide (H2S) sensors
H2S is an important gasotransmitter for the regulation of
biological processes involving cardiovascular, neuronal, immune,
endocrine, and gastrointestinal systems.77–79 Given the high
reactivity of H2S in biological environments, traditional detection
methods, e.g., colorimetric/electrochemical assays, gas chromatography, and sulfide precipitation, could yield inconsistent results
due to lengthy and/or destructive procedures.80–83 Consequently,
the reported biologically relevant concentrations of H2S vary over
a 105-fold range, from 100 pM to 300 mM.81,84–88
Recent reports described several small-molecule fluorescent
probes for H2S detection in living systems.89–94 All these designs
are based on H2S-specific reactions. A reaction-based FP sensor
for H2S was also constructed by Chen and co-workers.12 As
shown in Fig. 5, the chromophore-forming Tyr67 residue of teal
fluorescent protein (mTFP1) was replaced with pAzF. Chen and
co-workers hypothesized that the reduction of azide into an
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Fig. 5 pAzF-based FP biosensors for H2S detection. Two hypothetical pathways
that lead to the formation of chromophore 2 in the presence of H2S are shown.

amino group would change the fluorescence property of
this mTFP1 mutant. Indeed, they observed slightly increased
fluorescence after overnight incubation of mTFP1-Tyr67pAzF
protein with NaHS (an H2S precursor). The slow response may
be a result of the restricted accessibility of H2S to the chromophore of mTFP1 due to the protective beta-barrel structure of
the protein.12
To improve the kinetics of the obtained FP biosensor, Chen
and co-workers constructed a circularly permuted variant of
GFP (cpGFP-Tyr66pAzF) mutant in which the Tyr66 residue was
replaced with pAzF. Such modification led to about 3-fold
fluorescence enhancement after a few minutes of incubation
with 10 mM NaHS. The H2S-treated cpGFP-Tyr66pAzF displayed
the same excitation and emission profiles as those of an
authentic cpGFP variant containing chromophore 2 (Fig. 5).
To further confirm that the observed fluorescence change was a
result of the reduction of the azide by H2S, mass spectrometry
analysis of the cpGFP-Tyr66pAzF before and after the H2S
treatment was conducted. A mixture of cpGFPs containing
either premature (pre-chromophore 1; major peak) or mature
(chromophore 1, minor peak) azide-containing chromophores
was observed before H2S treatment. On the other hand, a major
peak that corresponds to cpGFP containing chromophore 2
was observed after H2S treatment. These results support the
authors’ initial hypothesis that the azide functional group was
reduced to an amino group by H2S. Based on these observations, two hypothetical pathways that led to the formation of
cpGFP containing chromophore 2 were suggested (Fig. 5). Pathway 1 that involves H2S-induced maturation of a chromophore
is the apparent major pathway. Chen and co-workers also
demonstrated a linear relationship between the magnitude of
fluorescence increase and the NaHS concentration when less
than 50 mM of NaHS was used. When cpGFP-Tyr66pAzF was
expressed in HeLa cells, the sensor responded to H2S within
minutes after the addition of 50 mM of NaHS. In comparison to
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small-molecule H2S sensors, the genetically encoded cpGFPTyr66pAzF should allow spatial resolution when it is fused to
cell localization signals. Therefore, this unnatural fluorescent
protein-based strategy for H2S detection adds new tools to
existing methodologies and should facilitate research on cellular production of H2S.

7. Light-responsive fluorescent proteins
Photoactivatable FPs are a class of useful probes used in cell
biology studies. This intriguing class of FPs undergoes irradiationdependent photochemical reactions or isomerizations that alter
spectral properties of the chromophores.95 Therefore, the photoactivatable FPs can be applied to the imaging of sub-populations
of cells and to experiments that require a higher resolution
than the theoretical diﬀraction limit of photoactivated light
microscopy.96,97 This family of FPs include Kaede,98 KikGR,98
Dronpa,99 and paGFP.100 Since the photoactivatable behavior of
these proteins relies on multiple sequence-specific mutations
of parent GFP variants, the construction of photoactivatable
FPs of other colors may require completely diﬀerent mutations
and/or strategies.
In order to develop a general applicable methodology for the
construction of photoactivatable FPs, Groﬀ and coworkers explored
the genetic incorporation of a photocaged tyrosine residue
(o-nitrobenzyl-O-tyrosine, ONBY; Fig. 2)46 into the chromophore

Fig. 6 ONBY-based photoactivatable FP. Photo-induced removal of the o-nitrobenzyl moiety converts a non-fluorescent chromophore into a wild-type GFP
chromophore.

Table 1

FP-based biosensors

Analyte

Sensor type

2+

Cu

Sensora

of a stabilized GFP variant (Fig. 6).14 As shown in Fig. 6, the
GFP66ONBY mutant is not fluorescent due to the photo-induced
electron transfer (PET) eﬀect. On the other hand, the removal of
the o-nitrobenzyl group by irradiation at 365 nm restored the
wild-type GFP fluorescence. The quantum yield (at 486 nm) of
GFP66ONBY mutant increased over 100-fold upon photolysis.
The observed fluorescence activation occurred on a timescale
faster than 1 s, which is comparable to transition rates of other
photoactivatable GFP variants.100 Since the photoactivation
mechanism of GFP66ONBY does not require the mutation of
amino acids residues besides Tyr66, this strategy may be readily
applicable to the generation of photoactivatable probes using
other fluorescent proteins as the templates.

8. Conclusion and future outlook
In this review, we described UAA*-containing FPs as a new class
of genetically-encoded and chemoselective biosensors. This
emerging new strategy expands the foundation of protein
sensor design beyond the 20 common amino acids that are
specified by the standard genetic code. The inclusion of new
functionalities in amino acid building blocks that are not
found in nature will improve our current ability to construct
selective FP biosensors. For example, the genetic incorporation
of pAzF enabled the construction of the first FP-based H2S
sensor. All examples in this review except sfGFP-151-HqAla
entail the substitution of the chromophore-forming tyrosine
residue with a UAA*. Because of the almost universal mechanism of chromophore formation in FPs (ECFP requires tryptophan and EBFP requires histidine instead of tyrosine), the
general design principle can be easily applied to other FPs
and can potentially lead to facile creation of biosensors with
diﬀerent colors.
Albeit a powerful approach, the use of UAA*-containing FP
biosensors for biological studies in living cells should be
adopted with caution. The amber stop codon is the most used

Selectivity
3+

Sensitivity

Maximum fold of
signal changeb

Reversibility

UAA*-based
UAA*-based
Non-UAA*-based

10

GFPdopa
sfGFP-151-HqAla13
HcRed101

Good (interfered by Fe )
Did not examine
Good

KD = 5.6 mM
KD = 0.1 fM
KD = 3.6 mM

>100
1.5–2
2–4

Yes
Yes
Yes

Zn2+

UAA*-based
Non-UAA*-based

cpsfGFP-66-HqAla13
eCALWYs47

Very good
Good (interfered by Pb2+,
Co2+, Pb2+)

KD = 50–100 mM
KD = 2 pM

2–3
2.4

Yes
Yes

H2O2

UAA*-based
Non-UAA*-based

UFP-Tyr66pBoPhe11
Hyper-1, 2, 370–72

Very good
Very good

Low mM
Medium nM

>100
B2–3

No
Yes

H2S

UAA*-based
Non-UAA*-based

cpGFP-Tyr66pAzF12
N/A

Good
N/A

Low mM
N/A

B7
N/A

No
N/A

Light

UAA*-based
Non-UAA*-based

GFP66ONBY14
Dronpa99

Very good
Very good

Good
Very good

>100
>100

No
Yes

a
Due to the limited space of the table, only representative non-UAA*-based FP biosensors are listed.
when the value is larger than 100.
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b

No specific fold of signal change is given
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triplet nonsense codon to encode UAA*s. Although studies
showed it has no detectable cytotoxicity to bacterial and mammalian cell culture,102–105 the heterologous expression of the
suppression system will result in undesirable read-throughs
that may cause nonlethal perturbations to cell physiology.
Recent efforts in orthogonal ribosome106,107 and quadruplet
codon decoding approaches are expected to address this issue
in cellular genetic code expansion.108–112 Another component
required for the expression of the UAA*-based biosensor is the
UAA* molecule. Unlike small-molecule sensors, UAA* itself
cannot produce signal readouts in the presence of an analyte.
However, UAA*s often possess the functional groups that can
react or bind to analytes. Therefore, complete removal of UAA*s
post FP sensor expression is necessary in order to achieve the
optimal sensor performance.
As shown in Table 1, reported UAA*-based FP biosensors
generally have good selectivity and decent fold of signal change
but lower than desirable sensitivity. Besides intrinsic limitations in the reactivity and/or binding aﬃnity of the UAA*, all
reported UAA*-based FP biosensors were recently developed
and not optimized, while some of the regular FP biosensors
were developed a decade ago and have been methodically
optimized as commercial products. Further protein engineering needs to be performed in order to improve the sensitivity
and the overall performance of UAA*-based FP biosensors.
Another less than desirable aspect of most reported UAA*based FP biosensors is that the sensor synthesis is largely
limited to the E. coli host. Due to the important roles of
small-molecule signaling in mammalian cells, eﬀorts must be
and are being made to enable mammalian expression of UAA*based FP biosensors. One major breakthrough in this direction
is the development of a method to genetically incorporate
ONBY (Fig. 2 and 6) into proteins in mammalian cells.104 Once
the UAA*-based FP biosensors are compatible with the mammalian system, the next step would be to construct functionally
equivalent FP biosensors of diﬀerent hues, which will enable
simultaneous detection of the same analyte in multiple subcellular compartments.
In addition to optimizing currently existing UAA*-containing
FP biosensors, future eﬀorts should also be devoted to the
design and synthesis of new sensors in order to expand the
scope of target molecules. This goal can be achieved by both
incorporating UAA*s with novel functional groups and exploiting
the diverse reactivity of already explored UAA*s. For example,
the mechanism and design principles of many small-molecule
biosensors, which are based on specific chemical reactions or
molecular interactions between the sensor molecule and the
analyte,113 could be implemented into the construction of UAA*based FP biosensors.
In summary, properties of reported UAA*-based FP biosensors need to be further optimized in order to be applied in real
biological studies. Nevertheless, these sensors represent the
first step towards the generation of highly sensitive and selective FP biosensors that may not be realized by following the
standard genetic code. We expect the creative integration of
modern protein engineering techniques with the expanded

2968

Mol. BioSyst., 2013, 9, 2961--2970

Molecular BioSystems
repertoire of amino acids building blocks to produce innovative
designs and applications of this new class of FP biosensors in
the near future.
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